influences chemotherapy delivery. 2 Therefore, selectively opening of BTB, improving the permeability of BTB and increasing anti-tumour medicine concentration in the brain tumour tissue provide a new approach to the treatment of glioma.
Circular RNAs (circRNAs) from back-spliced exons or intron-derived RNA have been recognized as a relatively new family of noncoding RNAs. They are found mainly in the cytoplasm and can be sorted into exosomes. 3 There is accumulating evidence indicates circRNAs serve as microRNA sponges or regulators of gene splicing and transcription to regulate gene expression. 4, 5 However, the functions of thousands of described circRNAs remain unclear. Recently, abnormal circRNA expressions have been demonstrated in various cardiovascular diseases and cancers, which are related to vascular dysfunction. [6] [7] [8] Knockdown of cZNF609, which is highly enriched in endothelial cells, diminished retinal vessel loss and inhibited pathological angiogenesis in vivo. 9 CircRNA USP1 (circ-USP1, also known as hsa_circ_0000080 according to circBase), which is located at chr1p31, is derived from the back-splicing of exon 6-8 of ubiquitin-specific peptidase 1 (USP1) gene. Circ-USP1 is significantly upregulated in our microarray screen detected by comparing human cerebral microvascular endothelial cell line (ECs) with endothelia cells co-cultured with glioma (GECs). Moreover, USP1 is highly expressed in glioblastoma, particularly in enriched glioblastoma stem-initiating cells. 10 Hence, circ-USP1 might be related to the dysregulation of endothelial cell functions.
MicroRNAs (miRNAs) are a kind of small conserved non-encoding RNA molecules that are involved in the post-transcriptional gene regulatory mechanism. MiRNAs have also been known to participate in a variety of physiological and pathological processes. 11, 12 Moreover, accumulating data indicate that miRNAs play crucial roles in regulating endothelial barrier function. [13] [14] [15] Decreased expression of miR-194-5p has been reported in various types of malignancy, including glioma, hepatoma carcinoma, gallbladder carcinoma and acute myeloid leukaemia. [16] [17] [18] [19] Overexpressed miR-194-5p in non-small-cell lung cancer suppresses cell migration, invasion and metastasis. 20 These reports indicate that miR-194-5p functions as a tumour suppressor in various human malignancies. could also modulate astrocyte-endothelial cell transition by driving expression of endothelial-specific genes, which indicated that miR-194-5p might play a role in regulating endothelial cell function. 21 MiR-194-5p was predicted to potentially target the circ-USP1 using CircInteractome database (https ://circi ntera ctome.nia.nih.gov/). Nevertheless, whether miR-194-5p might be involved in regulating BTB permeability remains to be investigated.
The highly conserved ETS transcription factors share a winged helix-turn-helix DNA-binding domain. 22 Friend leukaemia virus integration 1 (FLI1), as one of the ETS members, was initially uncovered as an oncogene as it is involved in retrovirus-induced haematological tumours in mice. 23 In human tissues, FLI1 is abnormally expressed in some solid tumours, including Ewing sarcoma, breast cancer and astrocytoma. [24] [25] [26] In endothelial cells, FLI1 is a regulator of vessel maturation and stabilization via modulating expressions of genes involved in maintaining vascular homoeostasis and integrity. 27, 28 However, a little attention has been directed to clarify the possible role of FLI1 in GECs and BTB permeability.
In our study, we explored the expressions of circ-USP1, miR-194-5p as well as FLI1 in GECs and elucidated their roles in the regulation of barrier permeability. We revealed that silencing circ-USP1 could increase the BTB permeability via miR-194-5p/FLI1-mediated regulation, which would provide a new therapeutic strategy of glioma.
| MATERIAL S AND ME THODS

| Cell lines and culture
The immortalized human cerebral microvascular endothelial cell line (hCMEC/D3, ECs) was kindly supplied by Dr Couraud (Institut Cochin, Paris, France). ECs were cultured as described previously. 29 Human glioma cell line U87MG and human embryonic kidney 293T (HEK293T) cell line were purchased from the Shanghai Institutes for Biological Sciences Cell Resource Center and were cultured in Dulbecco's modified Eagle medium of high glucose containing 10% foetal bovine serum, 100 U/mL penicillin and 100 μg/mL streptomycin (Life Technologies).
| Establishment of BTB model in vitro
The in vitro BTB model was established by co-culture of ECs and U87 cells as described previously. [29] [30] [31] Briefly, the U87 cells at a density of 2 × 10 4 per well were seeded in the six-well plate. Two days later, the ECs at a density of 2 × 10 5 per well were seeded onto the upper side of the Transwell insert (0.4 μm pore size;
Corning) coated freshly with 150 μg/mL of Cultrex Rat Collagen I (R&D Systems). The inserts were placed in the well of the sixwell plates containing U87 glioma cells and co-cultured for 4 days with prepared endothelial basal medium 2, and the medium was changed every 2 days. After co-culture with U87 glioma cells for 4 days, the ECs were called GECs.
| Circular RNA microarray analysis
Total RNA was extracted with Trizol reagent (Life Technologies).
Circular RNA microarray analysis was performed by Kanchen
Corporation. Microarray hybridization was performed according to the Arraystar's standard protocols.
| Real-time PCR assay
The expression of circ-USP1 was detected using One Step PrimeScript™ RT-PCR Kits (Takara, RR064A). The probe and primers of circ-USP1 and GAPDH were synthesized from Takara. The expression of linear USP1 was assessed by SYBR Premix Ex Taq and TaqMan gene expression assay kit (Applied Biosystems). The miR-194-5p and U6 expressions were determined using TaqMan MicroRNA Reverse Transcription kit and Taqman Universal Master Mix II (Applied Biosystems). Relative expression values were normalized and calculated with the relative quantification (2 −ΔΔCt ) method.
Probes and primers used for quantitative PCR (qPCR) were listed in Table S1 .
| Cell transfection
The short-hairpin circ-USP1 (circ-USP1 (−)), linear USP1 (lin-USP1 (−)) and FLI1 (FLI1 (−)) plasmids, and their respective negative control (NC), the non-targeting sequence, were ligated into a pGPU6/ GFP/Neo plasmid (GenePharma). FLI1 full length (FLI1 (+)) vector and its respective NC were reconstructed into a pIRES2-EGFP plasmid (GenScript). AgomiR-194-5p (miR-194-5p (+)), antagomiR-194-5p (miR-194-5p (−)) and their corresponding NC were synthesized (GenePharma).
ECs were transfected with Lipofectamine LTX and Plus reagent
(Life Technologies). G418 was used to select the stably transfected cells. The sequences for shRNA targeting circ-USP1, FLI1 and NC were showed in Table S2 .
| Transendothelial electric resistance (TEER) assays and horseradish peroxidase (HRP) assays
Before TEER assay was conducted using Millicell-ERS apparatus (Millipore), the inserts with ECs and U87 cells co-culture were leave in room temperature for 30 minutes. The medium was refreshed before the measurement. After subtracting the background resist- 
| Western blotting and immunofluorescence assays
Western blotting was performed as previously described. 29 Primary antibodies against GAPDH (Proteintech), FLI1 (Abcam), ZO-1 (Life Technologies), occludin (Abcam) and claudin-5 (Life Technologies) were used. Immunoblots were visualized using an enhanced chemiluminescence kit (ECL; Santa Cruz Biotechnology) and detected by The integrated light density values (IDV) were calculated and normalized with those of GAPDH. Distributions of claudin-5, occludin and ZO-1 were examined using immunofluorescence as reported previously. 29 
| Dual-luciferase reporter assay
The fragments of circ-USP1, lin-USP1 and FLI1 3′-UTR containing the potential miR-194-5p binding sites as well as their mutant binding sites were cloned into the pmirGlo Dual-luciferase miRNA Target Expression Vector (Promega) to construct the reporter vector (Generay Biotech Co.). HEK-293T cells were cotransfected with the above pmirGLO vectors and agomiR-194-5p or agomiR-194-5p-NC using Lipofectamine 3000 Reagents (Life Technologies). The relative firefly luciferase activity was determined 48 hours after transfection, and firefly luciferase activity was normalized by renilla luciferase activity.
| RNA immunoprecipitation (RIP) assay
RNA immunoprecipitation assays were conducted according to the instruction of the Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore). Briefly, cell lysates were incubated with RIP immunoprecipitation buffer containing magnetic beads conjugated with human anti-Ago2 antibody, and normal mouse IgG. Samples were incubated with Proteinase K, and then, immunoprecipitated RNA was purified and applied to qPCR.
| Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation assay was conducted using Simple ChIP Enzymatic Chromatin IP Kit (Cell signaling Technology) as previously described. 29 2% aliquots of lysates were used as input control, and the remaining lysates were immunoprecipitated with normal IgG or FLI1 antibody. Immunoprecipitated DNA was amplified using PCR by the primers listed in Table S3 . 
| Analysis of apoptosis by flow cytometry
| Statistical analysis
Experimental data were presented as the mean ± standard deviation and performed the statistical analysis using Student's t test (twotailed) and one-way analysis of variance (ANOVA) with GraphPad Prism 5 (GraphPad Software). Differences were considered to be statistically significant when P < .05. 
| Silence of circ-USP increased BTB permeability via reducing tight junction-related protein expressions in GECs
To uncover the function of circular RNA in endothelial cell dysregulation, microarray analysis was conducted to investigate the expression of circular RNA in GECs after the BTB models were successfully constructed. The results showed circ-USP1 was the most up-regulated circular RNA in GECs ( Figure S1 ). To further confirm this result, the endogenous expression of circ-USP1 in GECs was validated using TaqMan qRT-PCR. The expression of circ-USP1 was highly enriched in GECs compared to ECs ( Figure 1A ). The expression of linear USP1 (lin-USP1) was detected as well; no significant difference was found between ECs and GECs ( Figure S2A ). To further confirm the circular characteristics of circ-USP1, the enzyme RNase R which does not act on circular RNA was used. As expected, circ-USP1 was resistant to RNase R digestion, whilst lin-USP1 was significantly degraded ( Figure 1B and Figure S2B ). Furthermore, shRNA directed against the back splice sequence of circ-USP1 significantly decreased the expression of circ-USP1 by 72% and did not affect the expression of lin-USP1 ( Figure 1C and Figure S2C ). ShRNA targeted to the exonic sequences not shared by circ-USP1, only markedly knocked down the lin-USP1 expression ( Figure S2D ,E).
To further investigate whether circ-USP1 could regulate barrier function, the stable circ-USP1-knockdown ECs were used to establish the BTB model in vitro. TEER and HRP flux assays were performed to assess the barrier integrity and permeability. Figure 1F ). Furthermore, immunofluorescence analysis confirmed that in circ-USP1 (−)-NC group, more continuous distributions of tight junction-related proteins were observed. However, claudin-5, occludin and ZO-1 in circ-USP1 (−) group distributed discontinuously on the boundaries of cells ( Figure 1G ). Taken together, these data demonstrated that knockdown of circ-USP1 impaired the barrier integrity, increased permeability and reduced tight junction-related protein expressions in GECs.
| MiR-194-5p was involved in the regulation of BTB permeability and tight junction-related protein expressions in GECs
To examine the mechanism underlying circ-USP1 knockdown increases BTB permeability, we presumed that circ-USP1 might act as a miRNA sponge to adjust gene expression. To clarify which miRNAs might bind to circ-USP1, we assessed putative miRNAbinding sites on the circ-USP1 sequence using CircInteractome database. Among the 48 miRNAs candidates, miR-194-5p, which was recognized by circ-USP1 with an 8mer seed type, showed the highest context score percentile among the candidates belonging to the broadly conserved and conserved miRNA families. In GECs, miR-194-5p expression was decreased compared with ECs ( Figure 2A) . Then, the effects of miR-194-5p overexpression and knockdown on the barrier integrity and permeability were assessed using TEER and HRP flux assays. The overexpression and knockdown levels of miR-194-5p were assessed by qRT-PCR ( Figure 2B ). Figure 2C Figure 2F ). Therefore, the data above indicated that miR-194-5p impaired the integrity, increased barrier permeability via reducing claudin-5, occludin and ZO-1 expressions in GECs.
As indicated in
| Circ-USP1 bound to miR-194-5p to regulate BTB permeability
MiRNAs were identified to regulate mammalian gene expression at post-transcriptional levels by binding to Ago2. To investigate whether circ-USP1 possesses miR-194-5p-related functions by forming a complex with Ago2, RIP assay was performed. The data showed that circ-USP1 and miR-194-5p were significantly enriched in Ago2 immunoprecipitate compared to that of IgG. The miR-194-5p knockdown markedly down-regulated circ-USP1 and miR-194-5p levels immunoprecipitated with Ago2 ( Figure 3A,B) . To verify the prediction that circ-USP1 was targeted by miR-194-5p, the dual-lu- Figure 3C ). Moreover, no binding site was found between lin-USP1 and miR-194-5p.
To further explore whether circ-USP1 interact with miR-194-5p to regulate BTB permeability, antagomiR-194-5p was transfected into the stable circ-USP1 knockdown GECs. Then, TEER and HRP flux assays were investigated. As indicated in Figure 3D 
| FLI1 regulated BTB permeability via tight junction-related proteins
MiR-194-5p may act as a post-transcriptional regulator to regulate the BTB permeability via binding to the 3′UTR of target genes to repress protein production. By searching the TargetScan and mi-Randa bioinformatics database, FLI1 was predicted as a direct target of miR-194-5p. The FLI1 expression was first assessed in ECs and GECs. As indicated in Figure 4A ,B, FLI1 expression was markedly increased in GECs compared with the ECs. We also overexpressed or knocked down FLI1 in GECs ( Figure 4C Figure 4H ). To clarify whether FLI1 could directly bind to the promoters of claudin-5, occludin and ZO-1 in GECs, ChIP assays were conducted. FLI1 has been reported to bind to DNA through a consensus sequence GGAA/T. 22 According to the DBTSS HOME database, in claudin-5 were verified, respectively. Primers were designed to bind to the above FLI1 binding sequences as well as the negative control sequences in the upstream of the putative FLI1 binding sites, which was not predicted to bind to FLI1 (Table S3 ). The results demonstrated that FLI1 could bind to the putative binding sites of claudin-5, occludin and ZO-1, but not to the negative control groups ( Figure 4I -K).
| FLI1 was involved in circ-USP1-and miR-194-5p-mediated regulation of BTB permeability as a target of miR-194-5p
To identify that FLI1 is a functional target of miR-194-5p, the dual-luciferase reporter assay was conducted. Figure 5A Figure 6A 
| Combined treatment of circ-USP1 and miR-194-5p promoted doxorubicin delivery across BTB and induced apoptosis of glioma cells
In order to clarify whether the treatment of circ-USP1 and miR- Figure 7A) . A schematic representation of the mechanism by which the circ-USP1/miR-194-5p axis regulates the BTB permeability is presented in Figure 7B . The results above clarified for the first time that circ-USP1 modulated BTB permeability via a miR-194-5p/FLI1-mediated pathway.
Recently, increasing evidence proposes that circRNAs play a crucial role in the initiation and development of cancer. 32, 33 Studies have shown that circRNA ZNF292 silencing blocked glioma cell cycle progression through the regulation of Wnt/beta-catenin signalling pathway, thus suppressed gliomas cells proliferation. 34 CircRNAs are also abundantly enriched in vascular endothelial cells, however, the function of circRNAs remains unknown. In endothelial cells, cZNF292 was identified as the highest expressed circRNAs.
Depletion of cZNF292 inhibited angiogenic sprouting of endothelial cells suggested that cZNF292 showed a pro-angiogenic function. 35 In our study, circ-USP1 was highly expressed in GECs, whilst no significant difference was observed in the expression of lin-USP1 between ECs and GECs. Researchers verified that the expression of some circular isoforms, such as the circRNAs derived from the DCC (deleted in colorectal cancer) gene, diversified across a range of human tissues and was not correlated with its cognate linear mRNA expression. 36 Because of the up-regulation of circ-USP1 in GECs, we are interested to explore whether the dysregulation of circ-USP1 was associated with the regulation of BTB function. The down-regulation of tight junction-related proteins ZO-1, occludin and claudin-5 is a landmark change of BTB permeability via the paracellular pathway. 30, 31, 37 Knockdown of circ-USP1 reduced the expression of claudin-5, occludin and ZO-1, thus up-regulated BTB permeability.
These data indicated that circ-USP1 is involved in the regulation of BTB permeability.
We further explored the possible mechanisms of circ-USP1 in the regulation of barrier function. CircRNAs may act as a miRNA sponge to bind to miRNAs, and miRNAs would tether RISC to the circRNAs. The interaction between miRNA and circRNA may competitively affect miRNA-mediated regulation of their target genes. [38] [39] [40] In oral squamous cell carcinoma cells, circ_100290 plays oncogene function by binding with miR-29b. 41 We demonstrated that circ-USP1 may interact with miR-194-5p and function as an endogenous miR-194-5p sponge. Knockdown of circ-USP1 may result in the release of miR-194-5p and improved its activity. MiR-194 is a kind of the p53 responsive miRNAs, which has been reported to significantly suppress the proliferation and invasion of several cancer cells and acts as a tumour suppressor. 42, 43 MiR-194-5p has been found to be low expressed in glioma tissue and overexpression of miR-194-5p suppresses invasion and epithelial-mesenchymal transition of glioma cells. 44 Under serumdeprived condition, miR-194-5p was involved in the regulation of endothelial gene expression as well as the functional angiogenic activity. 21 In GECs, we found that miR-194-5p was low expressed.
Increased miR-194-5p reduced claudin-5, occludin and ZO-1 expressing levels, and up-regulated BTB permeability, which indicated that miR-194-5p may function as a novel regulator of BTB permeability.
In addition, bioinformatics analysis and luciferase reporter assay demonstrated that FLI1 acted as a target of miR-194-5p.
Overexpression of FLI1 reversed the miR-194-5p-induced increase of BTB permeability, which suggested FLI1 played a crucial role in miR-194-5p-mediated BBB permeability regulation. As a member of the ETS transcription factor family, FLI1 was known to regulate the expression of oncogenes, tumour suppressor genes, and some genes involved in maintaining vascular homoeostasis such as VE-cadherin, platelet endothelial cell adhesion molecule 1. 26, 28, 45 In GECs, we found that FLI1 was highly expressed and knockdown of FLI1 downregulated claudin-5, occludin and ZO-1 expression, which increased BTB permeability. Similarly, knockdown of FLI1 and ETS-related gene, its closest homolog, increased human pulmonary endothelial cell monolayer permeability with capacity like that of vascular endothelial growth factor. Meanwhile, the genes involved in the regulation endothelial homoeostasis and cell-cell adhesion were reduced. 28 Another finding inconsistent with our results is that in mice with a conditional deletion of FLI1 in endothelial cells exhibited disorganized dermal vasculature with obviously compromised vessel integrity and significantly increased vessel permeability. 45 Taken together, this study for the first time showed that highly expressed circ-USP1 acts as a regulator of BTB permeability. Knockdown of circ-USP1 impaired the BTB integrity increased BTB permeability via binding to miR-194-5p. The overexpressed miR-194-5p targeted transcription factor FLI1 to negatively regulate its expression, which resulted in the down-regulation of claudin-5, occludin and ZO-1. In summary, the circ-USP1/miR-194-5p/FLI1 pathway plays a crucial role in regulating BTB functions. 
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